Frontlight ResearchEarly access
Trial site
Praxis für interdisziplinäre Onkologie & Hämatologie
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Multiple myeloma1 trial
- Phase
- Phase 21 trial
- Status
- Recruiting3 trials
- Completed2 trials
- Withdrawn1 trial
- Lead sponsor
- iOMEDICO AG5 trials
- Dompé Farmaceutici S.p.A1 trial
Running trials
Recruiting
Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC
Withdrawn
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026